4 results
Approved WMOCompleted
The primary objective is to evaluating the impact of treatment on subject reported outcomes of their satisfaction and experience of treatment with VOLUMA® with Lidocaine (2ml or 1ml or a combination of both), for the mid-face area volume enhancement…
Approved WMOPending
To evaluate the safety and tolerability of crovalimab compared witheculizumab
Approved WMOPending
To evaluate the efficacy of crovalimab compared to eculizumab
Approved WMOPending
The primary objective is to develop and validate non-invasive portal pressure measurement by MRI in patients with end-stage liverdisease (ESLD).